Crossmark Global Holdings, Inc. Alkermes Plc. Put Options Transaction History
Crossmark Global Holdings, Inc.
- $5.61 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
363Shares Held
182MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$875 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$570 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$391 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$381 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$276 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.94B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...